Clearline Capital LP Theravance Biopharma, Inc. Transaction History

Clearline Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $4.29 Million - $6.38 Million	-577,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $3.91 Million - $8.33 Million	577,800 New	577,800 $4.28 Million
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $615,129 - $885,995	-37,258 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $581,224 - $937,038	37,258 New	37,258 $608,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.